D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
SunCoke Energy
SXC
$794M
| $13.3M | 0.01% |
1,550,973
-387,773
| -20% | -$3.36M |
|
|
MRX
1202
Marex Group Limited Ordinary Shares
MRX
$4.54B
| $13.3M | 0.01% |
+337,193
| New | +$14M |
|
1203
Kemper
KMPR
$1.81B
| $13.3M | 0.01% |
206,139
+167,482
| +433% | +$10.4M |
|
1204
RLX Technology
RLX
$2.37B
| $13.3M | 0.01% |
6,017,137
+1,567,208
| +35% | +$3.06M |
|
1205
Verra Mobility
VRRM
$775M
| $13.3M | 0.01% |
522,429
-298,710
| -36% | -$6.96M |
|
1206
Ezcorp Inc
EZPW
$1.79B
| $13.2M | 0.01% |
954,441
-941,399
| -50% | -$13.6M |
|
1207
CALL
Five Below
FIVE
$11.6B
| $13.2M | 0.01% |
100,900
+97,300
| +2,703% | +$9.48M |
|
1208
PUT
On Holding
ONON
$12.6B
| $13.2M | 0.01% |
253,900
+10,600
| +4% | +$540K |
|
1209
PUT
Boston Scientific
BSX
$68.4B
| $13.2M | 0.01% |
123,000
+67,400
| +121% | +$6.82M |
|
1210
Live Oak Bancshares
LOB
$1.98B
| $13.2M | 0.01% |
442,173
+57,687
| +15% | +$1.56M |
|
1211
Hovnanian Enterprises
HOV
$779M
| $13.2M | 0.01% |
125,991
-6,483
| -5% | -$635K |
|
1212
Celldex Therapeutics
CLDX
$2.94B
| $13.1M | 0.01% |
645,657
+239,496
| +59% | +$4.66M |
|
1213
CALL
Cadence Design Systems
CDNS
$91.6B
| $13.1M | 0.01% |
+42,600
| New | +$12.4M |
|
1214
CALL
Regeneron Pharmaceuticals
REGN
$72.9B
| $13.1M | 0.01% |
25,000
-13,300
| -35% | -$7.42M |
|
1215
Apollo Global Management
APO
$69B
| $13.1M | 0.01% |
92,390
-1,569,337
| -94% | -$208M |
|
1216
CALL
Toast
TOST
$18.9B
| $13.1M | 0.01% |
295,700
-81,200
| -22% | -$3.19M |
|
|
ALF
1217
Centurion Acquisition Corp
ALF
$390M
| $13.1M | 0.01% |
1,237,500
| – | – |
|
1218
Blackstone
BX
$104B
| $13.1M | 0.01% |
87,517
+49,076
| +128% | +$6.74M |
|
1219
SEI Investments
SEIC
$12.3B
| $13.1M | 0.01% |
+145,566
| New | +$11.7M |
|
1220
Pinterest
PINS
$13.7B
| $13.1M | 0.01% |
364,063
-437,985
| -55% | -$13.3M |
|
1221
ACI Worldwide
ACIW
$6.12B
| $13.1M | 0.01% |
284,339
+269,840
| +1,861% | +$13.3M |
|
1222
Cooper-Standard Automotive
CPS
$517M
| $13M | 0.01% |
605,904
+462,183
| +322% | +$8.9M |
|
1223
The RealReal
REAL
$1.41B
| $13M | 0.01% |
2,715,201
-1,329,951
| -33% | -$7.32M |
|
|
ACH
1224
Accendra Health
ACH
$254M
| $13M | 0.01% |
1,429,063
+616,830
| +76% | +$4.55M |
|
1225
Credicorp
BAP
$30.5B
| $13M | 0.01% |
58,168
-61,211
| -51% | -$12.4M |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.